2,355
Views
60
CrossRef citations to date
0
Altmetric
Original Articles

Body mass and weight thresholds for increased prosthetic joint infection rates after primary total joint arthroplasty

, , , , , , & show all
Pages 132-138 | Received 12 Aug 2013, Accepted 28 Sep 2013, Published online: 05 Jan 2016

  • Alexander J W, Solomkin J S, Edwards M J. Updated recommendations for control of surgical site infections. Ann Surg 2011; 253(6): 1082–93.
  • Anaya D A, Dellinger E P. The obese surgical patient: a susceptible host for infection. Surg Infect (Larchmt) 2006; 7(5): 473–80.
  • Andrew J G, Palan J, Kurup H V, Gibson P, Murray D W, Beard D J. Obesity in total hip replacement. J Bone Joint Surg Br 2008; 90(4): 424–429.
  • Barbour A, Schmidt S, Rout W R, Ben-David K, Burkhardt O, Derendorf H. Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery. Int J Antimicrob Agents 2009; 34(3): 231–5.
  • Bauer L A, Black D J, Lill J S. Vancomycin dosing in morbidly obese patients. Eur J Clin Pharmacol 1998; 54(8): 621–5.
  • Bordini B, Stea S, Cremonini S, Viceconti M, De Palma R, Toni A. Relationship between obesity and early failure of total knee prostheses. BMC Musculoskelet Disord 2009; 10: 29.
  • Bratzler D W, Dellinger E P, Olsen K M, Perl T M, Auwaerter P G, Bolon M K, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013; 70(3): 195–283.
  • Brill M J, Houwink A P, Schmidt S, Van Dongen E P, Hazebroek E J, van Ramshorst B, et al. Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis. J Antimicrob Chemother 2014; 69(3): 715–23.
  • Chesney D, Sales J, Elton R, Brenkel I J. Infection after knee arthroplasty a prospective study of 1509 cases. J Arthroplasty 2008; 23(3): 355–9.
  • Dowsey M M, Choong P F. Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty. Clin Orthop Relat Res 2008; 466(1): 153–8.
  • Falagas M E, Karageorgopoulos D E. Adjustment of dosing of antimicrobial agents for bodyweight in adults. Lancet 2010; 375(9710): 248–51.
  • Forse R A, Karam B, MacLean L D, Christou N V. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 1989; 106(4): 750–6; discussion 756-7.
  • Fujii T, Tsutsumi S, Matsumoto A, Fukasawa T, Tabe Y, Yajima R, et al. Thickness of subcutaneous fat as a strong risk factor for wound infections in elective colorectal surgery: impact of prediction using preoperative CT. Dig Surg 2010; 27(4): 331–5.
  • Haverkamp D, Klinkenbijl M N, Somford M P, Albers G H, van der Vis H M. Obesity in total hip arthroplasty–does it really matter? A meta-analysis. Acta Orthop 2011; 82(4): 417–22.
  • Janson B, Thursky K. Dosing of antibiotics in obesity. Curr Opin Infect Dis 2012; 25(6): 634–49.
  • Kalmeijer M D, van Nieuwland-Bollen E, Bogaers-Hofman D, de Baere G A. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000; 21(5): 319–323.
  • Kerkhoffs G M, Servien E, Dunn W, Dahm D, Bramer J A, Haverkamp D. The influence of obesity on the complication rate and outcome of total knee arthroplasty: a meta-analysis and systematic literature review. J Bone Joint Surg Am 2012; 94(20): 1839–44.
  • Lübbeke A, Garavaglia G, Barea C, Hoffmeyer P. Why do we need hospital-based registries? The Geneva Hip Arthroplasty Registry. Zürich, EFORT 2010: 1–20.
  • Marti A, Marcos A, Martinez J A. Obesity and immune function relationships. Obes Rev 2001; 2(2): 131–40.
  • Namba R S, Paxton L, Fithian D C, Stone M L. Obesity and perioperative morbidity in total hip and total knee arthroplasty patients. J Arthroplasty 2005; 20(7 Suppl 3): 46–50.
  • Namba R S, Inacio M C, Paxton E W. Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees. J Bone Joint Surg Am 2013; 95(9): 775–82.
  • Osmon D R, Berbari E F, Berendt A R, Lew D, Zimmerli W, Steckelberg J M, et al. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013; 56(1): 1–10.
  • Parvizi J, Gehrke T, Chen A F. Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Joint J 2013; 95-B(11): 1450–1452.
  • WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995; 854: 1–452.
  • Wilson J A, Clark J J. Obesity: impediment to wound healing. Crit Care Nurs Q 2003; 26(2): 119–32.